China

Home / China / Latest

Sinopharm applies for vaccine market approval

chinadaily.com.cn | Updated: 2020-11-25 14:29

Share

Share - WeChat

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd (Sinopharm) in Beijing, capital of China, April 10, 2020. [Photo/Xinhua]

Leading COVID-19 vaccine developer Sinopharm has submitted a market approval application to the top market regulator, according to media reports.

Photo

19th Chinese Bridge foreign participants tour Beijing

Heilongjiang begins autumn rice harvest across black soil fields

Colorful activities mark Teachers' Day across China

Snow leopard repeatedly spotted in Gansu's Qilian Mountains

Evacuated residents returning home after Gyirong mudslide

Neighbors give Lao hospitals healthy dose of support

Latest

State Council News

Policies concerning expats, foreign enterprises in August 2026

Exclusive

Hands off! Do robots do it all by themselves?

Middle school students teach humanoid robots to dance!

Taking robot show to the next level

Newsmaker

12-year-old wins two honors at national rocket competition

Olympic champ quits Shanghai sports bureau post

Special Coverage

105th founding anniv. of the CPC

75th anniv. of Xizang's peaceful liberation

BACK TO THE TOP

English

中文

Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Registration Number: 130349

About China Daily

Advertise on Site

Expat Employment

FOLLOW US